Penumbra - PEN Stock Forecast, Price & News

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PEN shares.
View PEN analyst ratings or view top-rated stocks.

9 equities research analysts have issued twelve-month price targets for Penumbra's stock. Their PEN share price forecasts range from $163.00 to $300.00. On average, they anticipate the company's share price to reach $228.90 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for PEN or view top-rated stocks among Wall Street analysts.

Penumbra's stock was trading at $287.32 on January 1st, 2022. Since then, PEN stock has decreased by 36.7% and is now trading at $181.79.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our PEN earnings forecast.

Penumbra, Inc. (NYSE:PEN) announced its earnings results on Thursday, August, 4th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.08. The firm had revenue of $208.30 million for the quarter, compared to analysts' expectations of $206.24 million. Penumbra had a positive trailing twelve-month return on equity of 0.97% and a negative net margin of 2.40%. The business's quarterly revenue was up 13.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.21 EPS.

Penumbra issued an update on its FY 2022 earnings guidance on Thursday, August, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $860.00 million-$875.00 million, compared to the consensus revenue estimate of $869.01 million.

57 employees have rated Penumbra Chief Executive Officer Adam Elsesser on Glassdoor.com. Adam Elsesser has an approval rating of 88% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), AbbVie (ABBV), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Netflix (NFLX), UnitedHealth Group (UNH), Boeing (BA) and DexCom (DXCM).

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

Penumbra's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (14.92%), Baillie Gifford & Co. (3.38%), Price T Rowe Associates Inc. MD (3.25%), Clearbridge Investments LLC (2.69%), William Blair Investment Management LLC (2.58%) and State Street Corp (2.56%). Insiders that own company stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Coyne David, Don W Kassing, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Sridhar Kosaraju, Surbhi Sarna and Thomas Wilder.
View institutional ownership trends.

Shares of PEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PEN stock can currently be purchased for approximately $181.79.

Penumbra (NYSE:PEN) has a market capitalization of $6.89 billion and generates $747.59 million in revenue each year. The company earns $5.28 million in net income (profit) each year or ($0.52) on an earnings per share basis.

The company employs 3,800 workers across the globe.

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The official website for the company is www.penumbrainc.com. The company can be reached via phone at (510) 748-3200, via email at investors@penumbrainc.com, or via fax at 510-748-3232.